Clinical perspectives from the BEGIN and EDITION programmes: Trial-level meta-analyses outcomes with either degludec or glargine 300 U/mL vs glargine 100 U/mL in T2DM

Clinical perspectives from the BEGIN and EDITION programmes: Trial-level meta-analyses outcomes with either degludec or glargine 300 U/mL vs glargine 100 U/mL in T2DM. Roussel, R.; Ritzel, R.; Boëlle-Le Corfec, E.; Balkau, B.; Rosenstock, J.. Diabetes & Metabolism. 2018; : . doi:10.1016/j.diabet.2018.02.002
Article